| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Anti-angiogenic therapy in the setting of TACE: an elusive synergy?
|
Odisio, Bruno C
|
|
2018
|
3 |
1 |
p. 5-6
|
article
|
| 2 |
Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial
|
Hamaguchi, Tetsuya
|
|
2018
|
3 |
1 |
p. 47-56
|
article
|
| 3 |
Changing paradigms in adjuvant treatment of colorectal cancer
|
Lordick, Florian
|
|
2018
|
3 |
1 |
p. 6-8
|
article
|
| 4 |
Correction to Lancet Gastroenterol Hepatol 2017; 2: 877–89
|
|
|
2018
|
3 |
1 |
p. e1
|
article
|
| 5 |
Effect of diagnosis, surveillance, and treatment of Barrett's oesophagus on health-related quality of life
|
Britton, James
|
|
2018
|
3 |
1 |
p. 57-65
|
article
|
| 6 |
Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial
|
Johnsen, Peter Holger
|
|
2018
|
3 |
1 |
p. 17-24
|
article
|
| 7 |
Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial
|
Newsome, Philip Noel
|
|
2018
|
3 |
1 |
p. 25-36
|
article
|
| 8 |
Haemopoietic stem cell therapy in cirrhosis: the end of the story?
|
Lanthier, Nicolas
|
|
2018
|
3 |
1 |
p. 3-5
|
article
|
| 9 |
Making optical biopsy a clinical reality in colonoscopy
|
East, James E
|
|
2018
|
3 |
1 |
p. 10-12
|
article
|
| 10 |
Microbiome analysis: ready for clinical use?
|
The Lancet Gastroenterology & Hepatology,
|
|
2018
|
3 |
1 |
p. 1
|
article
|
| 11 |
Minimum alcohol pricing in Scotland
|
The Lancet Gastroenterology & Hepatology,
|
|
2018
|
3 |
1 |
p. 1
|
article
|
| 12 |
Of milk and microbes
|
Burki, Talha Khan
|
|
2018
|
3 |
1 |
p. 16
|
article
|
| 13 |
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
|
Kudo, Masatoshi
|
|
2018
|
3 |
1 |
p. 37-46
|
article
|
| 14 |
Research in brief
|
Baker, Holly
|
|
2018
|
3 |
1 |
p. 15
|
article
|
| 15 |
Stool as a treatment for IBS: more questions than answers?
|
Ford, Alexander C
|
|
2018
|
3 |
1 |
p. 2-3
|
article
|
| 16 |
The painful reality of end-stage liver disease in NASH
|
Ratziu, Vlad
|
|
2018
|
3 |
1 |
p. 8-10
|
article
|
| 17 |
25th UEG Week
|
Brierley, Rob
|
|
2018
|
3 |
1 |
p. 14
|
article
|
| 18 |
Too much medicine: overdiagnosis and overtreatment of non-alcoholic fatty liver disease
|
Rowe, Ian A
|
|
2018
|
3 |
1 |
p. 66-72
|
article
|
| 19 |
What drives the hypoalgesic effect of neurostimulation?
|
Albusoda, Ahmed
|
|
2018
|
3 |
1 |
p. 13
|
article
|
Journal description